Toxic epidermal necrosis following Sinopharm COVID-19 vaccine
(BBIBP-CorV): A case report and literature review
This study reports a patient developing TEN after the first dose of
(BBIBP-CorV). He developed numerous purpuric and dusky patches with
flaccid bullae and areas of epidermal detachment covered more than 30%
of the body area within 6 days. After treatment with dexamethasone and
cyclosporin, he recovered within 14 days.